The present Flavouring Group Evaluation 209 (FGE.209), corresponding to subgroup 2.3 of FGE.19, concerns one cyclic aldehyde with the alpha,beta-unsaturation in conjugation with the ring system. The alpha,beta-unsaturated aldehyde and ketone structures are considered alerts for genotoxicity and the data on genotoxicity previously available did not rule out the concern for genotoxicity. Accordingly, the Panel has requested additional genotoxicity data for this substance, 2,6,6-trimethylcyclohexa-1,3-diene-1-carbaldehyde ], according to the test strategy.
Flavouring Group Evaluation 19 (FGE.19) contains 360 flavouring substances from the EU Register being alpha, beta-unsaturated aldehydes or ketones and precursors which could give rise to such carbonyl substances via hydrolysis and / or oxidation (EFSA, 2008b).
The alpha, beta-unsaturated aldehyde and ketone structures are structural alerts for genotoxicity. The Panel noted that there were limited genotoxicity data on these flavouring substances but that positive genotoxicity studies were identified for some substances in the group.
The alpha, beta-unsaturated carbonyls were subdivided into 28 subgroups on the basis of structural similarity (EFSA, 2008b) . In an attempt to decide which of the substances could go through the Procedure, a (quantitative) structure-activity relationship (Q)SAR prediction of the genotoxicity of these substances was undertaken considering a number of models (DEREKfW, TOPKAT, DTU-NFIMultiCASE Models and ISS-Local Models, (Gry et al., 2007) ).
The Panel noted that for most of these models internal and external validation has been performed, but considered that the outcome of these validations was not always extensive enough to appreciate the validity of the predictions of these models for these alpha, beta-unsaturated carbonyls. Therefore, the Panel considered it inappropriate to totally rely on (Q)SAR predictions at this point in time and decided not to take substances through the procedure based on negative (Q)SAR predictions only.
The Panel took note of the (Q)SAR predictions by using two ISS Local Models (Benigni & Netzeva, 2007a; Benigni & Netzeva, 2007b) and four DTU-NFI MultiCASE Models (Gry et al., 2007; Nikolov et al., 2007) and the fact that there are available data on genotoxicity, in vitro and in vivo, as well as data on carcinogenicity for several substances. Based on these data the Panel decided that 15 subgroups (1.1.1, 1.2.1, 1.2.2, 1.2.3, 2.1, 2.2, 2.3, 2.5, 3.2, 4.3, 4.5, 4.6, 5.1, 5.2 and 5.3) (EFSA, 2008b) could not be evaluated through the Procedure due to concern with respect to genotoxicity. Corresponding to these subgroups, 15 Flavouring Group Evaluations (FGEs) were established, FGE.200, 204, 205, 206, 207, 208, 209, 211, 215, 219, 221, 222, 223, 224 and 225) .
For 11 subgroups the Panel decided, based on the available genotoxicity data and (Q)SAR predictions, that a further scrutiny of the data should take place before requesting additional data from the Flavouring Industry on genotoxicity. These subgroups were evaluated in FGE.201, 202, 203, 210, 212, 213, 214, 216, 217, 218 and 220 . For the substances in FGE.202, 214 and 218 it was concluded that a genotoxic potential could be ruled out and accordingly these substances will be evaluated using the Procedure. For all or some of the substances in the remaining FGEs, FGE.201. 203, 210, 212, 213, 216, 217 and 220 the genotoxic potential could not be ruled out. EFSA Journal 2011; 9(3):1992
To easy the data retrieval of the large number of structurally related alpha,beta-unsaturated substances in the different subgroups for which additional data are requested, EFSA has worked out a list of representative substances for each subgroup (EFSA, 2008bc) . Likewise an EFSA genotoxicity expert group has worked out a test strategy to be followed in the data retrieval for these substances (EFSA, 2008bb) .
The Flavouring Industry has been requested to submit additional genotoxicity data according to the list of representative substances and test strategy for each subgroup.
The Flavouring Industry has now submitted additional data and the present FGE concerns the evaluation of these data requested on genotoxicity.
TERMS OF REFERENCE
The European Commission requests the European Food Safety Authority to carry out an evaluation of the data on 2,6,6-Trimethylcyclohexa-1,3-diene-1-carbaldehyde 
ASSESSMENT

1.
Presentation of the substance in the JECFA Flavouring Group
Description
The present Flavouring Group Evaluation 209 (FGE.209), corresponding to subgroup 2.3 of FGE.19, concerns one cyclic aldehyde with the alpha,beta-unsaturation in conjugation with the ring system. The substance under consideration in the present evalution is shown in Table 1 .
The substance has previously been evaluated by the JECFA (JECFA, 2002b), a summary of the current evalution status by the JECFA and the outcome of this consideration is presented in Table 2 .
The alpha,beta-unsaturated aldehyde and ketone structures are considered alerts for genotoxicity (EFSA, 2008b) and the data on genotoxicity previously available did not rule out the concern for genotoxicity.
Representative substances for subgroup 2.3
As subgroup 2.3 of FGE.19 only concerns one substance, The Panel has requested additional genotoxicity data according to the test strategy (EFSA, 2008bb) for this substance. The substance is shown in table 1.1. 
Introduction
The Industry has submitted data concerning genotoxicity studies for the representative and only substance for this subgroup, 2,6,6-trimethylcyclohexa-1,3-diene-1-carbaldehyde [FL-no: 05.104] (safranal).
2.1.
In vitro data
In vitro genotoxicity assays have been performed on the alpha,beta-unsaturated aldehyde safranal [FLno: 05.104].
Bacterial Reverse Mutation Assay
Safranal has been tested for its ability to induce gene mutations in the bacterial reverse mutation assay according to OECD guideline 471 (Beevers, 2010b ) (for details see Table 3 ). The concentrations used in the different experiments were based on concentrations observed to give toxic effects in previous experiments. Positive and negative controls were included in all experiments according to current guidelines.
There were some increases in revertant numbers in TA102 in the absence and presence of S9 in the first experiment, but these were of insufficient magnitude to be considered as evidence of mutagenicity, they were not concentration-related, and were not reproducible in the other experiments. In all other strains there was no evidence of mutagenic activity either in the absence or presence of S9 in any of the experiments.
It is concluded that under the test conditions applied safranal did not induce gene mutations in bacteria.
Micronucleus assays
Safranal was evaluated in an in vitro micronucleus assay in human peripheral blood lymphocytes for its ability to induce chromosomal damage or aneuploidy in the presence and absence of S9 (Whitwell, 2010c) . The maximum soluble concentration of 1250 μg/ml was selected as the maximum concentration for the cytotoxicity range finder test. The concentrations in the main tests were based on toxicity shown in this range finding study (for details see Table 3 ).
At the highest concentration used in the 3+21 hour treatment in the presence of S9, a small statistical increase in the frequency of micronucleated binucleate cells (MNBN) was observed, but this was set against a low mean concurrent vehicle control response. This concentration induced 62 % cytotoxicity, and there was no statistically significant increase in MNBN at the next lowest concentration, which induced 42 % cytotoxicity. Therefore, this isolated increase was not considered to be of biological importance. Outside of this isolated observation at a high level of toxicity, no evidence of chromosomal damage or aneuploidy was observed in terms of any increase in the frequency of MNBN in the presence or absence of S9.
It is concluded that under the conditions of this study, safranal did not induce micronuclei in cultured human lymphocytes.
In vivo data
Based on the in vitro data available no in vivo data are needed. Although this flavouring substance showed evidence of cytotoxicity at high concentrations, it did not induce biologically significant genotoxic responses.
Discussion of Mutagenicity/Genotoxicity Data
Conclusion
The in vitro genotoxicity data on 2,6,6-trimethylcyclohexa-1,3-diene- Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot.
4)
No safety concern based on intake calculated by the MSDI approach of the named compound.
5)
Data must be available on the substance or closely related substances to perform a safety evaluation. [1] 3 hours treatment 21 hours recovery without S9.
[2] 3 hours treatment 21 hours recovery with S9.
[3] 24 hours treatment no recovery without S9.
[4] The assays were performed according to OECD guideline 471 and in compliance with GLP.
[5] This assay is performed in accordance with OECD 487.
